SEMAGLITUDE (WEGOVY / OZEMPIC)
“The New ‘Game-Changing’ Weight-Loss Medicine!”
– New York Times
With the help of this new medical weight loss drug, Semaglutide, you may finally lose weight and keep it off!
Semaglutide is an injectable prescription medical weight loss drug for adults struggling to lose weight.
Start Today For As Little As $199!
*minimum purchase required
What is the most important information I should know about Semaglutide?
What is Semaglutide (Wegovy/Ozempic)?
- Semaglutide has been previously approved to treat Type-2 Diabetes.
- A study in 2021 showed promising results for Semaglutide aiding in weight loss.
- In 2021, the FDA approved Semaglutide for medical weight loss.
How does Semaglutide (Wegovy/Ozempic) work?
- Acts on centers in the brain to suppress appetite, making your brain think you are full, decreasing the ability to over-eat and snack later.
- Could prevent and treat diabetes, cardiovascular disease and related complications, including osteoarthritis and sleep apnea.
- Leads to losing weight 5x faster than diet and exercise alone.
- Can help balance hormones like insulin.
What are the benefits of Semaglutide (Wegovy/Ozempic)?
Losing 5% to 10% of body weight through diet and exercise alone has been associated with a reduced risk of cardiovascular disease in adult patients with obesity or overweight.
Benefits may include:
- Reduces food intake by lowering appetite.
- Slows food digestion in the stomach.
- Decrease body fat percentage.
- Weight loss.
- Decreased cardiovascular outcomes in subjects with type 2 diabetes and cardiovascular disease.
- Lower HbA1c levels.
- Enhance the growth of β cells in the pancreas.
What is the dosage of Semaglutide (Wegovy/Ozempic) for medical weight loss?
The medication dose must be increased gradually over 16 to 20 weeks to 2.4 mg once weekly to reduce gastrointestinal side effects.
Common dosing is as follows:
- Weeks 1-4: inject 0.25 mg once a week
- Weeks 5-8: inject 0.5 mg once a week
- Weeks 9-12: inject 1 mg once a week
- Weeks 13-16: inject 1.7 mg once a week
- Weeks 17+: inject 2.4 mg once a week
Is Semaglutide (Wegovy/Ozempic) safe to use for medical weight loss?
The largest placebo-controlled trial enrolled adults without diabetes. The average age at the start of the trial was 46 years and 74% of patients were female.
The average body weight was 231 pounds (105 kg) and average BMI was 38 kg/m2. Individuals who received Wegovy lost an average of 12.4% of their initial body weight compared to individuals who received placebo.
Another trial enrolled adults with type 2 diabetes. The average age was 55 years and 51% were female. The average body weight was 220 pounds (100 kg) and average BMI was 36 kg/m2.
In this trial, individuals who received Wegovy lost 6.2% of their initial body weight compared to those who received placebo.
Is there a shortage of Semaglutide (Wegovy/Ozempic)?
Don’t let the news scare you. At this time, Semaglutide is readily available nationwide. Semaglutide is manufactured by independent compounding pharmacies daily and can be shipped to you overnight.